These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21364239)
21. Transradial approach versus transfemoral approach for coronary angiography and coronary angioplasty. Mullin MK Crit Care Nurs Q; 2014; 37(2):159-69. PubMed ID: 24595253 [TBL] [Abstract][Full Text] [Related]
22. Cost analysis of bivalirudin in percutaneous coronary intervention. Lauer MA J Invasive Cardiol; 2000 Dec; 12 Suppl F():37F-40. PubMed ID: 11156733 [No Abstract] [Full Text] [Related]
23. The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction. Kessler DP; Kroch E; Hlatky MA Am Heart J; 2011 Sep; 162(3):494-500.e2. PubMed ID: 21884866 [TBL] [Abstract][Full Text] [Related]
24. Transradial approach to all interventional procedures a matter of the learning curve. Pawlowski T; Kulawik T; Gil RJ JACC Cardiovasc Interv; 2010 Apr; 3(4):463; author reply 463-4. PubMed ID: 20398879 [No Abstract] [Full Text] [Related]
25. Incidence of bleeding in renally impaired patients receiving incorrectly dosed eptifibatide or bivalirudin while undergoing percutaneous coronary intervention. Taylor LA; Mauro VF Ann Pharmacother; 2012 Jan; 46(1):35-41. PubMed ID: 22170973 [TBL] [Abstract][Full Text] [Related]
26. Bivalirudin has its own shelf in the cath lab, eventually. Cortese B; Pitì A Int J Cardiol; 2012 Oct; 160(3):153-4. PubMed ID: 22357425 [No Abstract] [Full Text] [Related]
27. Transradial PCI in women: problem solved or clinical equipoise? Rao SV; Krucoff MW J Invasive Cardiol; 2011 Mar; 23(3):4 p preceding 101. PubMed ID: 21476236 [No Abstract] [Full Text] [Related]
28. Comparison of frequency of radial artery occlusion after 4Fr versus 6Fr transradial coronary intervention (from the Novel Angioplasty USIng Coronary Accessor Trial). Takeshita S; Asano H; Hata T; Hibi K; Ikari Y; Kan Y; Katsuki T; Kawasaki T; Masutani M; Matsumura T; Premchand RK; Rao SP; Suzuki T; Takahashi A; Takeda R; Tanaka S; Yamazaki S; Yin WH; Yoshimachi F; Saito S; Am J Cardiol; 2014 Jun; 113(12):1986-9. PubMed ID: 24786357 [TBL] [Abstract][Full Text] [Related]
29. [Clinical and economical evaluation of bivalirudin during percutaneous coronary interventions]. Caruba T; Chaïb A; Danchin N; Rahal S; Bégué D; Durand E; Prognon P; Lafont A; Sabatier B Ann Cardiol Angeiol (Paris); 2010 Apr; 59(2):72-8. PubMed ID: 19962685 [TBL] [Abstract][Full Text] [Related]
30. Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function. Roguin A; Steinberg BA; Watkins SP; Resar JR Int J Cardiovasc Intervent; 2005; 7(2):88-92. PubMed ID: 16093217 [TBL] [Abstract][Full Text] [Related]
31. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III). Waksman R; Bertrand O; Driesman M; Gruberg L; Rossi J; Mehta S; Swymelar S; Dvir D; Xue Z; Torguson R J Interv Cardiol; 2013 Apr; 26(2):107-13. PubMed ID: 23240743 [TBL] [Abstract][Full Text] [Related]
33. Transradial arterial access for coronary and peripheral procedures: executive summary by the Transradial Committee of the SCAI. Caputo RP; Tremmel JA; Rao S; Gilchrist IC; Pyne C; Pancholy S; Frasier D; Gulati R; Skelding K; Bertrand O; Patel T Catheter Cardiovasc Interv; 2011 Nov; 78(6):823-39. PubMed ID: 21544927 [TBL] [Abstract][Full Text] [Related]
34. Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. Tarantini G; Brener SJ; Barioli A; Gratta A; Parodi G; Rossini R; Navarese EP; Niccoli G; Frigo AC; Musumeci G; Iliceto S; Stone GW Am Heart J; 2014 Mar; 167(3):401-412.e6. PubMed ID: 24576526 [TBL] [Abstract][Full Text] [Related]
35. Safety of bivalirudin in patients with coronary artery disease. Abdel-Wahab M; Richardt G Expert Opin Drug Saf; 2012 Jan; 11(1):141-50. PubMed ID: 21999110 [TBL] [Abstract][Full Text] [Related]
36. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260 [TBL] [Abstract][Full Text] [Related]
37. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study). Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760 [TBL] [Abstract][Full Text] [Related]
38. Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital. Olchanski N; Slawsky KA; Plent S; Kado C; Cyr PL Hosp Pract (1995); 2010 Nov; 38(4):138-46. PubMed ID: 21068538 [TBL] [Abstract][Full Text] [Related]
39. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures. Chew DP Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763 [TBL] [Abstract][Full Text] [Related]
40. Radial artery spasm during transradial cardiac catheterization and percutaneous coronary intervention: incidence, predisposing factors, prevention, and management. Ho HH; Jafary FH; Ong PJ Cardiovasc Revasc Med; 2012; 13(3):193-5. PubMed ID: 22226169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]